Browsing by Author "Loric, Sylvain"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Gefitinib Inhibits the Growth and Invasion of Urothelial Carcinoma Cell Lines in which Akt and MAPK Activation Is Dependent on Constitutive Epidermal Growth Factor Receptor Activation
    (American Association for Cancer Research, 2006) Nicolle, Gaëlle; Daher, Ahmed; Maillé, Pascale; Vermey, Marcel; Loric, Sylvain; Bakkar, Ashraf; Wallerand, Hervé; Vordos, Dimitrios; Vacherot, Francis; Gil Diez De Medina, Sixtina; C Abbou, Claude; Van der Kwast, Theodore; Thiery, Jean-Paul; Radvanyi, François; K Chopin, Dominique
    Abnormally high levels of epidermal growth factor receptor (EGFR) protein are associated with advanced tumor stage/grade. The objective of this study was to evaluate the effects of the specific EGFR tyrosine kinase inhibitor gefitinib on activation of the Akt and mitogen-activated protein kinase (MAPK) pathways in human urothelial cell carcinoma (UCC) cell lines and to identify potential markers of gefitinib responsiveness in biopsy samples of UCC.